Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 38

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 38
---
 applicable securities Laws). “Merger” means the merging of Merger Sub with and into APx, with APx surviving such merger and becoming a direct wholly -ownedsubsidiary of the Company. “Merger Consideration” means the Company Shares and Company Warrants receivable by SPAC Shareholders pursuant to the Business Combination Agreement. “Merger Effective Time” means such time at which the Plan of Merger is registered by the Cayman Registrar in accordance with the Cayman Companies Act or at such later date and/or time permitted by the Cayman Companies Act as may be agreed by Merger Sub and SPAC in writing with the prior written consent of the Company and specified in the Plan of Merger, provided that such later time shall not be a date later than the ninetieth (90 th) day after the date when the Plan of Merger is filed and registered with the Cayman Registrar. “Merger Sub” means Heritas Merger Sub Limited, a Cayman Islands exempted company and a direct wholly -ownedsubsidiary of the Company. “MultiplAI” means MultiplAI Health Ltd, a private limited company formed under the laws of England and Wales. “MultiplAI Acquisition” means the sale and purchase of all the ordinary shares of MultiplAI Health Ltd (and, if required under the MultiplAI Share Purchase Agreement, all of the MultiplAI Shareholders’ rights and interest in the options granted to any of the MultiplAI Shareholders under all existing share option or similar option schemes of MultiplAI, and all of MultiplAI Shareholders’ rights and interest in certain equity related agreements and convertible securities, as well as any related ancillary documents or agreements). “MultiplAI Shareholder” means any holder of any MultiplAI Shares. “MultiplAI Shares” means the ordinary shares, par value £0.0001, of MultiplAI and any other equity commitments or Equity Securities of MultiplAI, including any securities or commitments convertible into, exchangeable or exercisable for, or representing the right to subscribe for, any ordinary shares, par value £0.0001, of MultiplAI. “MultiplAI Share Purchase Agreement” means the amended and restated share purchase agreement dated March 13, 2024, among the Parent, MultiplAI and the MultiplAI Shareholders, which amends and restates that certain share purchase agreement entered into on January 23, 2024, by and among the Parent,